Shingrix shortage: Advice for physicians
With demand for the newer shingles vaccine, known as Shingrix, far outstripping the pace at which the manufacturer can supply it, shortages will likely continue throughout 2019, predicts the CDC.
“GlaxoSmithKline [GSK] are running their vaccine plants as much as they can, to produce more but it’s just not enough,” says Julio Viola, PharmD, the director of centralized pharmacy services at Northwell Health Systems, which operate in the New York metro area.
Source: ConsultantLive - Category: Internal Medicine Authors: Milly Dawson Tags: Medical News Source Type: news